nivolumab,ipilimumab
bms
['niche,(-niche 2),(-niche-2),(-niche2)']
the effectiveness of neoadjuvant immunotherapy in patients with dmmr colon cancer was shown for the first time in the exploratory niche trial in which pathological responses was achieved in 100%of dmmr tumours, indicating the feasibility of this approach. #esmo2022
Smiling! :) like always!
Interest: Oncology, Medicine, Art, Music, Movies, Literature, Theater, AND BEING HAPPY! :)